• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (42)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Bacterial Infections  • Chronic Obstructive Pulmonary Disease  • Pneumonia  • Quality of Care  • Evidence-Based Medicine  • Drug Therapy  • Adverse Effects  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

A Meta-analysis

Sonal Singh, MD, MPH; Aman V. Amin, MD; Yoon K. Loke, MD

Arch Intern Med. 2009;169(3):219-229.

Background  Recent studies have suggested a possible association between pneumonia and the use of inhaled corticosteroids. We aimed to ascertain the risk of pneumonia with long-term inhaled corticosteroid use among patients with chronic obstructive pulmonary disease (COPD).

Methods  We performed systematic searches with no date restrictions through June 30, 2008, of MEDLINE, EMBASE, the Cochrane Database of Systematic Reviews, regulatory documents, and trial registries. We included randomized controlled trials of any inhaled corticosteroid vs a control treatment for COPD, with at least 24 weeks of follow-up and reporting of pneumonia as an adverse event. Outcomes evaluated included any pneumonia, serious pneumonia, pneumonia-related mortality, and overall mortality.

Results  Eighteen randomized controlled trials (n = 16 996) with 24 to 156 weeks of follow-up were included after a detailed screening of 97 articles. Inhaled corticosteroids were associated with a significantly increased risk of any pneumonia (relative risk [RR], 1.60; 95% confidence interval [CI], 1.33-1.92 [P < .001]; I² = 16%) and serious pneumonia (1.71; 1.46-1.99 [P < .001]; I² = 0%) but without a significantly increased risk of pneumonia-related mortality (1.27; 0.80-2.03 [P = .31]; I² = 0%) or overall mortality (0.96; 0.86-1.08 [P = .51]; I² = 0%). Inhaled corticosteroids were associated with a significantly increased risk of serious pneumonia when compared with placebo (RR, 1.81; 95% CI, 1.44-2.29 [P < .001]) or when the combination of inhaled corticosteroids and long-acting β-agonists was compared with long-acting β-agonists (1.68; 1.20-2.34 [P = .002]).

Conclusion  Among patients with COPD, inhaled corticosteroid use for at least 24 weeks is associated with a significantly increased risk of serious pneumonia, without a significantly increased risk of death.

Author Affiliations: Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina (Drs Singh and Amin); Clinical Pharmacology, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, England (Dr Loke).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pharmacotherapeutic Approaches to Preventing Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Han and Martinez
Proc Am Thorac Soc 2011;8:356-362.
ABSTRACT | FULL TEXT  

To Use or Not to Use: Clinical Decision Making in the Face of Uncertainty
Rennard and Vestbo
Am. J. Respir. Crit. Care Med. 2011;184:284-285.
FULL TEXT  

Observational Study of Inhaled Corticosteroids on Outcomes for COPD Patients with Pneumonia
Chen et al.
Am. J. Respir. Crit. Care Med. 2011;184:312-316.
ABSTRACT | FULL TEXT  

Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies
Loke et al.
Thorax 2011;66:699-708.
ABSTRACT | FULL TEXT  

Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia
Singanayagam et al.
Eur Respir J 2011;38:36-41.
ABSTRACT | FULL TEXT  

Long-term use of thiazolidinediones and the associated risk of pneumonia or lower respiratory tract infection: systematic review and meta-analysis
Singh et al.
Thorax 2011;66:383-388.
ABSTRACT | FULL TEXT  

Risks of Pneumonia in Patients with Asthma Taking Inhaled Corticosteroids
O'Byrne et al.
Am. J. Respir. Crit. Care Med. 2011;183:589-595.
ABSTRACT | FULL TEXT  

Preventing exacerbations in chronic obstructive pulmonary disease
Drug and Therapeutics Bulletin
BMJ 2011;342:c7207-c7207.
FULL TEXT  

Preventing exacerbations in COPD
DTB 2010;48:74-77.
ABSTRACT | FULL TEXT  

Combination therapy with long-acting {beta}-agonists plus inhaled corticosteroids is no more effective than LABA monotherapy for mortality outcomes and severe exacerbations in moderate to very severe COPD and is associated with serious adverse effects
Frith
Evid. Based Med. 2010;15:78-79.
FULL TEXT  

Prevention of exacerbations of COPD with pharmacotherapy
Miravitlles
Eur Respir Rev 2010;19:119-126.
ABSTRACT | FULL TEXT  

Inhaled corticosteroids and risk of pneumonia: evidence for and against the proposed association
Singanayagam et al.
QJM 2010;103:379-385.
ABSTRACT | FULL TEXT  

Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD
Loke et al.
Eur Respir J 2010;35:1003-1021.
ABSTRACT | FULL TEXT  

Update in Chronic Obstructive Pulmonary Disease 2009
Cosio and Agusti
Am. J. Respir. Crit. Care Med. 2010;181:655-660.
FULL TEXT  

Inhaled Corticosteroids vs Placebo for Preventing COPD Exacerbations: A Systematic Review and Metaregression of Randomized Controlled Trials
Agarwal et al.
Chest 2010;137:318-325.
ABSTRACT | FULL TEXT  

Predicting Corticosteroid Response in Chronic Obstructive Pulmonary Disease Using Exhaled Nitric Oxide
Dummer et al.
Am. J. Respir. Crit. Care Med. 2009;180:846-852.
ABSTRACT | FULL TEXT  

Safety and Efficacy of Combined Long-Acting {beta}-Agonists and Inhaled Corticosteroids vs Long-Acting {beta}-Agonists Monotherapy for Stable COPD: A Systematic Review
Rodrigo et al.
Chest 2009;136:1029-1038.
ABSTRACT | FULL TEXT  

All you need to read in the other general journals
BMJ 2009;338:b627-b627.
FULL TEXT  

Chronic Obstructive Pulmonary Disease
Braman
ACCP Pulmonary Med Brd Rev 2009;25:153-186.
FULL TEXT